// App-Quantinova.ai

: CSF amyloid, tau, and neurodegeneration biomarkers are associated with longitudinal cognitive decline in preclinical AD

Researchers

Presenter

  • Karly Alex Cody

Principal Investigators

  • Tobey J Betthauser

  • Carol A. Van Hulle

  • Rebecca Langhough Koscik

  • Erin M Jonaitis

  • Lindsay R. Clark

  • Nathaniel A Chin

  • Ozioma C. Okonkwo

  • Barbara B. Bendlin

  • Sanjay Asthana

  • Ivonne Suridjan

  • Gwendlyn Kollmorgen

  • Henrik Zetterberg

  • Cynthia M Carlsson

  • Kaj Blennow

  • Sterling C. Johnson

Medical Centers

  • Wisconsin Alzheimer’s Institute, University of Wisconsin School of Medicine and Public Health

  • Division of Geriatrics and Gerontology, Department of Medicine, University of Wisconsin- Madison School of Medicine and Public Health

  • Division of Geriatrics and Gerontology, Department of Medicine, University of Wisconsin- Madison School of Medicine and Public Health

  • University of Wisconsin-Madison School of Medicine and Public Health

  • Wisconsin Alzheimer’s Institute, University of Wisconsin School of Medicine and Public Health

  • Wisconsin Alzheimer’s Institute, University of Wisconsin School of Medicine and Public Health

  • Wisconsin Alzheimer’s Institute, University of Wisconsin School of Medicine and Public Health

  • Geriatric Research Education and Clinical Center, William S. Middleton Veterans Hospital

  • Institute of Neuroscience & Physiology, Department of Psychiatry & Neurochemistry, The Sahlgrenska Academy, University of Gothenburg

  • Division of Geriatrics and Gerontology, Department of Medicine, University of Wisconsin- Madison School of Medicine and Public Health

  • Geriatric Research Education and Clinical Center, William S. Middleton Veterans Hospital

  • Wisconsin Alzheimer’s Institute, University of Wisconsin School of Medicine and Public Health

  • 6. Department of Neurology University of Wisconsin-Madison School of Medicine and Public Health

  • Roche Diagnostics International AG

  • Institute of Physiology and Neuroscience, University of Gothenburg

  • Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Sweden

  • William S. Middleton Memorial VA Hospital-GRECC, Madison, WI

  • Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London

  • Wisconsin Alzheimer’s Institute, University of Wisconsin School of Medicine and Public Health

  • Wisconsin Alzheimer’s Institute, University of Wisconsin School of Medicine and Public Health

  • UK Dementia Research Institute

  • Wisconsin Alzheimer’s Institute, University of Wisconsin School of Medicine and Public Health

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Alzheimer's disease

Biomarkers

  • Amyloid beta 42

  • Cerebrospinal fluid

  • Neurofilament-light chain

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved